High-level beta-globin expression and preferred intragenic integration after lentiviral transduction of human cord blood stem cells.

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Journal of Clinical Investigation

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  PMID 15467834PMCID PMC518665
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Expression of an anti-sickling beta-globin in human erythroblasts derived from retrovirally transduced primitive normal and sickle cell disease hematopoietic cells.

  2004cited by this paper
• The impact of low-dose busulfan on clonal dynamics in nonhuman primates.

  2004cited by this paper
• Lentivector-mediated clonal tracking reveals intrinsic heterogeneity in the human hematopoietic stem cell compartment and culture-induced stem cell impairment.

  2004cited by this paper
• Cytokines, including stem cell factor alone, enhance lentiviral transduction in nondividing human LTCIC and NOD/SCID repopulating cells.

  2003cited by this paper
• Correction of a mouse model of sickle cell disease: lentiviral/antisickling beta-globin gene transduction of unmobilized, purified hematopoietic stem cells.

  2003cited by this paper
• In vivo selection of MGMT(P140K) lentivirus-transduced human NOD/SCID repopulating cells without pretransplant irradiation conditioning.

  2003cited by this paper
• LMO2-Associated Clonal T Cell Proliferation in Two Patients after Gene Therapy for SCID-X1

  2003cited by this paper
• Transcription Start Regions in the Human Genome Are Favored Targets for MLV Integration

  2003cited by this paper
• Immune-deficient mouse models for analysis of human stem cells.

  2003cited by this paper
• The degree of phenotypic correction of murine beta -thalassemia intermedia following lentiviral-mediated transfer of a human gamma-globin gene is influenced by chromosomal position effects and vector copy number.

  2003cited by this paper
• Lentiviral gene transfer into peripheral blood-derived CD34+ NOD/SCID-repopulating cells.

  2002cited by this paper
• Development of gene therapy for hematopoietic stem cells using lentiviral vectors

  2002cited by this paper
• Permanent and panerythroid correction of murine β thalassemia by multiple lentiviral integration in hematopoietic stem cells

  2002cited by this paper
• Germline Transmission and Tissue-Specific Expression of Transgenes Delivered by Lentiviral Vectors

  2002cited by this paper
• HIV-1-derived lentiviral vectors.

  2002cited by this paper
• Gene transfer into hematopoietic stem cells using lentiviral vectors.

  2002cited by this paper
• Lentiviral gene transfer and ex vivo expansion of human primitive stem cells capable of primary, secondary, and tertiary multilineage repopulation in NOD/SCID mice. Nonobese diabetic/severe combined immunodeficient.

  2002cited by this paper
• Maximal lentivirus-mediated gene transfer and sustained transgene expression in human hematopoietic primitive cells and their progeny.

  2002cited by this paper
• HIV-1 integration in the human genome favors active genes and local hotspots.

  2002cited by this paper
• Molecular evidence of lentiviral vector-mediated gene transfer into human self-renewing, multi-potent, long-term NOD/SCID repopulating hematopoietic cells.

  2002cited by this paper
• Successful treatment of murine beta-thalassemia intermedia by transfer of the human beta-globin gene.

  2002cited by this paper
• Expression of a human beta-globin transgene in erythroid cells derived from retrovirally transduced transplantable human fetal liver and cord blood cells.

  2002cited by this paper
• Functional requirements for phenotypic correction of murine beta-thalassemia: implications for human gene therapy.

  2001cited by this paper
• The sequence of the human genome (abstract only)

  2001cited by this paper
• Previously undetected human hematopoietic cell populations with short-term repopulating activity selectively engraft NOD/SCID-beta2 microglobulin-null mice.

  2001cited by this paper
• Gene therapy: promises and problems.

  2001cited by this paper
• Correction of Sickle Cell Disease in Transgenic Mouse Models by Gene Therapy

  2001cited by this paper
• Avoidance of stimulation improves engraftment of cultured and retrovirally transduced hematopoietic cells in primates.

  2001cited by this paper
• Initial sequencing and analysis of the human genome

  2001cited by this paper
• Efficient retrovirus-mediated gene transfer to transplantable human bone marrow cells in the absence of fibronectin.

  2000cited by this paper
• Lentiviral vectors.

  2000cited by this paper
• Expansion of human cord blood CD34(+)CD38(-) cells in ex vivo culture during retroviral transduction without a corresponding increase in SCID repopulating cell (SRC) frequency: dissociation of SRC phenotype and function.

  2000cited by this paper
• Lentiviral gene transfer into primary and secondary NOD/SCID repopulating cells.

  2000cited by this paper
• Preselection of retrovirally transduced bone marrow avoids subsequent stem cell gene silencing and age-dependent extinction of expression of human beta-globin in engrafted mice.

  2000cited by this paper
• Therapeutic haemoglobin synthesis in beta-thalassaemic mice expressing lentivirus-encoded human beta-globin.

  2000cited by this paper
• During ontogeny primitive (CD34(+)CD38(-)) hematopoietic cells show altered expression of a subset of genes associated with early cytokine and differentiation responses of their adult counterparts.

  2000cited by this paper
• Transduction of human CD34+ CD38- bone marrow and cord blood-derived SCID-repopulating cells with third-generation lentiviral vectors.

  2000cited by this paper
• Gene transfer by lentiviral vectors is limited by nuclear translocation and rescued by HIV-1 pol sequences

  2000cited by this paper
• Human hematopoietic stem cells stimulated to proliferate in vitro lose engraftment potential during their S/G(2)/M transit and do not reenter G(0).

  2000cited by this paper
• One-day ex vivo culture allows effective gene transfer into human nonobese diabetic/severe combined immune-deficient repopulating cells using high-titer vesicular stomatitis virus G protein pseudotyped retrovirus.

  1999cited by this paper
• Stable transduction of quiescent CD34(+)CD38(-) human hematopoietic cells by HIV-1-based lentiviral vectors.

  1999cited by this paper
• Differentiation stage-specific regulation of primitive human hematopoietic progenitor cycling by exogenous and endogenous inhibitors in an in vivo model.

  1999cited by this paper
• The beta-thalassemias.

  1999cited by this paper
• Functional differences between transplantable human hematopoietic stem cells from fetal liver, cord blood, and adult marrow.

  1999cited by this paper
• Transduction of human CD34+ cells that mediate long-term engraftment of NOD/SCID mice by HIV vectors.

  1999cited by this paper
• Optimization of retroviral-mediated gene transfer to human NOD/SCID mouse repopulating cord blood cells through a systematic analysis of protocol variables.

  1999cited by this paper
• Genetic treatment of severe hemoglobinopathies: the combat against transgene variegation and transgene silencing.

  1998cited by this paper
• HIV, but not murine leukemia virus, vectors mediate high efficiency gene transfer into freshly isolated G0/G1 human hematopoietic stem cells.

  1998cited by this paper
• Serial bone marrow sampling for long-term follow up of human hematopoiesis in NOD/SCID mice.

  1998cited by this paper
• Nonobese diabetic/severe combined immunodeficiency (NOD/SCID) mouse as a model system to study the engraftment and mobilization of human peripheral blood stem cells.

  1998cited by this paper
• Hematopoietic stem cells: Inferences from in vivo assays

  1997cited by this paper
• Long-term transfer and expression of the human beta-globin gene in a mouse transplant model.

  1997cited by this paper
• Primitive human hematopoietic cells are enriched in cord blood compared with adult bone marrow or mobilized peripheral blood as measured by the quantitative in vivo SCID-repopulating cell assay.

  1997cited by this paper
• Expansion in vitro of transplantable human cord blood stem cells demonstrated using a quantitative assay of their lympho-myeloid repopulating activity in nonobese diabetic-scid/scid mice.

  1997cited by this paper
• Barriers to bone marrow transplantation for sickle cell anemia.

  1996cited by this paper
• A second generation transgenic mouse model expressing both hemoglobin S (HbS) and HbS-Antilles results in increased phenotypic severity.

  1995cited by this paper
• Generation of a high-titer retroviral vector capable of expressing high levels of the human beta-globin gene.

  1995cited by this paper
• Mutagenesis of retroviral vectors transducing human beta‐globin gene and beta‐globin locus control region derivatives results in stable transmission of an active transcriptional structure.

  1994cited by this paper
• Selection of retrovirally transduced hematopoietic cells using CD24 as a marker of gene transfer.

  1994cited by this paper
• A human beta-globin gene fused to the human beta-globin locus control region is expressed at high levels in erythroid cells of mice engrafted with retrovirus-transduced hematopoietic stem cells.

  1993cited by this paper
• DNaseI hypersensitive sites 1, 2 and 3 of the human beta-globin dominant control region direct position-independent expression.

  1990cited by this paper
• A novel, rapid method for the isolation of terminal sequences from yeast artificial chromosome (YAC) clones.

  1990cited by this paper
• A majority of mice show long-term expression of a human beta-globin gene after retrovirus transfer into hematopoietic stem cells

  1989cited by this paper
• A dominant control region from the human β-globin locus conferring integration site-independent gene expression

  1989cited by this paper
• Characterization and partial purification of human marrow cells capable of initiating long-term hematopoiesis in vitro.

  1989cited by this paper
• Lineage-specific expression of a human β-globin gene in murine bone marrow transplant recipients reconstituted with retrovirus-transduced stem cells

  1988cited by this paper
• The regulation of expression of human beta-globin genes.

  1987cited by this paper
• Evidence for a locus activation region: the formation of developmentally stable hypersensitive sites in globin-expressing hybrids.

  1987cited by this paper
• The "beta-like-globin" gene domain in human erythroid cells.

  1985cited by this paper
• Mapping of DNase I-hypersensitive sites in the upstream DNA of human embryonic epsilon-globin gene in K562 leukemia cells.

  1984cited by this paper
• DNA sequences required for regulated expression of beta-globin genes in murine erythroleukemia cells.

  1984cited by this paper

• Receptor Tyrosine Kinase Profiling Identifies Chronic Constitutive Floodgate Oxidative Signaling in Glutathione-Independent Human Mammary Luminal Progenitor Cells

  2025cites this paper
• The research on the treatment of primary immunodeficiency diseases by hematopoietic stem cell transplantation: A bibliometric analysis from 2013 to 2022

  2023cites this paper
• Long-term outcomes of lentiviral gene therapy for the β-hemoglobinopathies: the HGB-205 trial

  2022cites this paper
• Evolution of Gene Therapy, Historical Perspective.

  2022cites this paper
• Therapy Development by Genome Editing of Hematopoietic Stem Cells

  2021cites this paper
• The Future of Gene Therapy for Transfusion-Dependent Beta-Thalassemia: The Power of the Lentiviral Vector for Genetically Modified Hematopoietic Stem Cells

  2021cites this paper
• Enhanced Transduction of Human Hematopoietic Stem Cells by AAV6 Vectors: Implications in Gene Therapy and Genome Editing

  2020cites this paper
• Innovative Therapies for Hemoglobin Disorders

  2020cites this paper
• Isolation and characterization of a new basal-like luminal progenitor in human breast tissue

  2019cites this paper
• Long Non-Coding RNA H19 Acts as an Estrogen Receptor Modulator that is Required for Endocrine Therapy Resistance in ER+ Breast Cancer Cells

  2018cites this paper
• Clonal analysis of human mammary cell transformation and X-ray sensitivity

  2018cites this paper
• Major Advances in the Development of Vectors for Clinical Gene Therapy of Hematopoietic Stem Cells from European Groups over the Last 25 Years

  2017cites this paper
• Gene therapy for hemoglobin disorders - a mini-review

  2016cites this paper
• Notch-Induced Expression of FZD7 Requires Noncanonical NOTCH3 Signaling in Human Breast Epithelial Cells

  2016cites this paper
• Characterization of Epithelial Progenitors in Normal Human Palatine Tonsils

  2016cites this paper
• Gene Therapy of the β-Hemoglobinopathies by Lentiviral Transfer of the βA(T87Q)-Globin Gene

  2016cites this paper
• VENTX induces expansion of primitive erythroid cells and contributes to the development of acute myeloid leukemia in mice

  2016cites this paper
• Gene Therapy for Hemoglobinopathies: Tremendous Successes and Remaining Caveats.

  2016cites this paper
• Current and future alternative therapies for beta-thalassemia major

  2016cites this paper
• Recent trends in the gene therapy of β-thalassemia

  2015cites this paper
• Modeling Normal and Disordered Human Hematopoiesis.

  2015cites this paper
• A New Approach in Gene Therapy of Glioblastoma Multiforme: Human Olfactory Ensheathing Cells as a Novel Carrier for Suicide Gene Delivery

  2015cites this paper
• Characterization of Epithelial Progenitors in Normal Human Palatine Tonsils and Their HPV16 E6/E7-Induced Perturbation

  2015cites this paper
• Dominant-negative IKAROS enhances IL-3-stimulated signaling in wild-type but not BCR-ABL1(+) mouse BA/F3 cells.

  2015cites this paper
• Disruption of IKAROS activity in primitive chronic-phase CML cells mimics myeloid disease progression.

  2015cites this paper
• Globin gene regulation for treating β-thalassemias: progress, obstacles and future

  2015cites this paper
• Barcoding reveals complex clonal dynamics of de novo transformed human mammary cells

  2015cites this paper
• Clonal analysis via barcoding reveals diverse growth and differentiation of transplanted mouse and human mammary stem cells.

  2014cites this paper
• A Dominant-Negative Isoform of IKAROS Expands Primitive Normal Human Hematopoietic Cells

  2014cites this paper
• Delineating Structural Characteristics of Viral Capsid Proteins Critical for Their Functional Assembly.

  2014cites this paper
• Gene therapy: a novel way to treat respiratory failure?

  2014cites this paper
• Gene Localization and Transcriptional Dynamics in the Optimization of Transgene Expression

  2013cites this paper
• Lycorine hydrochloride selectively inhibits human ovarian cancer cell proliferation and tumor neovascularization with very low toxicity.

  2013cites this paper
• High-Efficiency Transduction of Primary Human Hematopoietic Stem Cells and Erythroid Lineage-Restricted Expression by Optimized AAV6 Serotype Vectors In Vitro and in a Murine Xenograft Model In Vivo

  2013cites this paper
• Combining gene therapy and fetal hemoglobin induction for treatment of β-thalassemia

  2013cites this paper
• The Lin28b–let-7–Hmga2 axis determines the higher self-renewal potential of fetal haematopoietic stem cells

  2013cites this paper
• Development of gene therapy for thalassemia.

  2012cites this paper
• Recent advances in gene therapy for thalassemia

  2012cites this paper
• Improvement of deficits by transplantation of lentiviral vector-modified human amniotic mesenchymal cells after cerebral ischemia in rats.

  2012cites this paper
• Hematopoietic stem cells: transcriptional regulation, ex vivo expansion and clinical application.

  2012cites this paper
• Alternative options for DNA-based experimental therapy of β-thalassemia

  2012cites this paper
• Physiological and tissue-specific vectors for treatment of inherited diseases

  2011cites this paper
• Recombinant AAV2-mediated β-globin expression in human fetal hematopoietic cells from the aborted fetuses with β-thalassemia major

  2011cites this paper
• Distribution of lentiviral vector integration sites in mice following therapeutic gene transfer to treat β-thalassemia.

  2011cites this paper
• Functional Regulation of Pre-B-cell Leukemia Homeobox Interacting Protein 1 (PBXIP1/HPIP) in Erythroid Differentiation*

  2011cites this paper
• Therapeutic levels of fetal hemoglobin in erythroid progeny of β-thalassemic CD34+ cells after lentiviral vector-mediated gene transfer.

  2011cites this paper
• Major challenges for gene therapy of thalassemia and sickle cell disease.

  2010cites this paper
• Genetic Correction of Sickle Cell Anemia and β-Thalassemia: Progress and New Perspective

  2010cites this paper
• Hemoglobin gene therapy for β-thalassemia.

  2010cites this paper
• Genetic therapy for beta-thalassemia: from the bench to the bedside.

  2010cites this paper
• Therapy for β‐globinopathies: a brief review and determinants for successful and safe correction

  2010cites this paper
• Engineering the mouse genome to model human disease for drug discovery.

  2010cites this paper
• Genotoxic Potential of Lineage-specific Lentivirus Vectors Carrying the β-Globin Locus Control Region.

  2009cites this paper
• Gene Therapy in Thalassemia and Hemoglobinopathies

  2009cites this paper
• Hematopoietic stem cell gene transfer for the treatment of hemoglobin disorders.

  2009cites this paper
• Retroviral vectors encoding ADA regulatory locus control region provide enhanced T-cell-specific transgene expression

  2009cites this paper
• Future alternative therapies for β-thalassemia

  2009cites this paper
• Murine Leukemia Virus as a Vector to Transfer Genes into Blood Stem Cells : Success in Two Immunodeficiency Disorders

  2009cites this paper
• Genotoxic potential of lineage-specific lentivirus vectors carrying the beta-globin locus control region.

  2009cites this paper
• Ex vivo liver-directed gene therapy for the treatment of metabolic diseases: advances in hepatocyte transplantation and retroviral vectors.

  2009cites this paper
• In vivo selection of genetically modified erythroblastic progenitors leads to long-term correction of β-thalassemia

  2008cites this paper
• [Advances in sickle cell disease].

  2008cites this paper
• Transcriptome analysis of the normal human mammary cell commitment and differentiation process.

  2008cites this paper
• Unaltered repopulation properties of mouse hematopoietic stem cells transduced with lentiviral vectors.

  2008cites this paper
• ON THE ROAD TO GENE THERAPY FOR β-THALASSEMIA AND SICKLE CELL ANEMIA

  2008cites this paper
• Transplantation of neural stem cells modified by human neurotrophin-3 promotes functional recovery after transient focal cerebral ischemia in rats.

  2008cites this paper
• β-Globin LCR and Intron Elements Cooperate and Direct Spatial Reorganization for Gene Therapy

  2008cites this paper
• Optimization of Recombinant Adeno-Associated Viral Vectors for Human β-Globin Gene Transfer and Transgene Expression

  2008cites this paper
• Overexpression of CDX2 perturbs HOX gene expression in murine progenitors depending on its N-terminal domain and is closely correlated with deregulated HOX gene expression in human acute myeloid leukemia.

  2008cites this paper
• Exploitation of stem cell homing for gene delivery

  2008cites this paper
• Progress toward safe and effective gene therapy for beta-thalassemia and sickle cell disease.

  2008cites this paper
• Current status of globin gene therapy for the treatment of β‐thalassaemia

  2008cites this paper
• Gene replacement therapy for sickle cell disease and other blood disorders.

  2008cites this paper
• AML1-ETO Collaborates with the Homeobox Gene Meis1 in Inducing Acute Leukemia in the Mouse Bone Marrow Transplantation Model.

  2008cites this paper
• Improved purification of hematopoietic stem cells based on their elevated aldehyde dehydrogenase activity

  2007cites this paper
• Design of a trans protease lentiviral packaging system that produces high titer virus

  2007cites this paper
• Murine leukemia following irradiation conditioning for transplantation of lentivirally‐modified hematopoietic stem cells

  2007cites this paper
• HUMAN AMNIOTIC EPITHELIAL CELLS AMELIORATE BEHAVIORAL DYSFUNCTION AND REDUCE INFARCT SIZE IN THE RAT MIDDLE CEREBRAL ARTERY OCCLUSION MODEL

  2007cites this paper
• Modification of globin gene expression by RNA targeting strategies.

  2007cites this paper
• Effects of Bicistronic Lentiviral Vector–Mediated Herpes Simplex Virus Thymidine Kinase/Ganciclovir System on Human Lens Epithelial Cells

  2007cites this paper
• Erythroid-specific expression of beta-globin by the sleeping beauty transposon for Sickle cell disease.

  2007cites this paper
• Locus control region elements HS1 and HS4 enhance the therapeutic efficacy of globin gene transfer in beta-thalassemic mice.

  2007cites this paper
• Report on the Workshop “New Technologies in Stem Cell Research,” Society for Pediatric Research, San Francisco, California, April 29, 2006

  2007cites this paper
• Improved human beta-globin expression from self-inactivating lentiviral vectors carrying the chicken hypersensitive site-4 (cHS4) insulator element.

  2007cites this paper
• Multiarm High-Throughput Integration Site Detection: Limitations of LAM-PCR Technology and Optimization for Clonal Analysis

  2007cites this paper
• Tolerogenic property of MHC class I and class II molecules: lessons from a gene therapy approach.

  2007cites this paper
• Platelet-Directed Gene Therapy

  2007cites this paper
• TRANSDUCTION OF COS-7 AND K562 CELL LINES BY RECOMBINANT LENTIVIRAL PARTICLES CARRYING MINILCR AND β-GLOBIN GENE: INTRODUCTION TO GENE THERAPY OF MAJOR β-THALASSEMIA

  2007cites this paper
• Gene therapy strategies towards immune tolerance to treat the autoimmune diseases.

  2006cites this paper
• Gene therapy: can neural stem cells deliver?

  2006cites this paper
• Gene therapy for treatment of inherited haematological disorders

  2006cites this paper
• Anatomical Compartments Modify the Response of Human Hematopoietic Cells to a Mitogenic Signal

  2006cites this paper
• Mutagenesis and Oncogenesis by Chromosomal Insertion of Gene Transfer Vectors

  2006cites this paper
• A novel single step double positive double negative selection strategy for beta-globin gene replacement.

  2006cites this paper
• The reduction and induction of Kaposi's sarcoma-associated herpesvirus lytic replication

  2006cites this paper
• Genotoxicity of retroviral integration in hematopoietic cells.

  2006cites this paper
• Hematopoietic stem cell gene transfer in a tumor-prone mouse model uncovers low genotoxicity of lentiviral vector integration

  2006cites this paper
• Lentiviral vector integration sites in human NOD/SCID repopulating cells

  2006cites this paper
• Prolonged Adherence of Human Immunodeficiency Virus-Derived Vector Particles to Hematopoietic Target Cells Leads to Secondary Transduction In Vitro and In Vivo

  2006cites this paper
• Retrovirus vectors: toward the plentivirus?

  2006cites this paper